Stock Insiders: Aroa Biosurgery isn’t wasting time counting sheep
Health & Biotech
Stock Insiders is a podcast series focussed on investing, hosted by TV presenter and news journalist Christina Morrissy.
In this episode Christina chats to Dr Brian Ward, CEO of Aroa Biosurgery (ASX:ARX).
Soft tissue regeneration company Aroa Biosurgery was founded in 2008 by Dr Ward after he discovered extracellular matrix (ECM), a tissue scaffold found in the forestomach of sheep, closely resembled human tissue in structure and contained more than 150 essential proteins crucial for healing.
Most recently, Aroa has successfully maintained its FY24 product revenue guidance at NZ$72-75 million, representing a 25-30% increase on FY23 on a constant currency basis after a solid Q2.
To hear Christina and Brian discuss all this and more, tune in below!
Like to tune in through another app? Just search for Stock Insiders with Christina Morrissy and subscribe!